Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice

Experimental Neurology

Volumn 272, Issue , 2015, Pages 78-87

  Sun, Jinmei ^a,b   Wei, Zheng Zachory ^a,b   Gu, Xiaohuan ^b   Zhang, James Ya ^b   Zhang, Yongbo ^a   Li, Jimei ^a   Wei, Ling ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypoxic preconditioning; Intracerebral hemorrhage; Intranasal transplantation; Neurogenesis; Stroke

Indexed keywords

DOUBLECORTIN PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NEUROPEPTIDE;

ANIMAL; ATROPHY; BRAIN; BRAIN HEMORRHAGE; C57BL MOUSE; COMPLICATION; CONVALESCENCE; DISEASE MODEL; GENE EXPRESSION REGULATION; INTRANASAL DRUG ADMINISTRATION; ISCHEMIC PRECONDITIONING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MOTOR ACTIVITY; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM DISEASES; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOMOTOR PERFORMANCE; STROKE; TIME;

ADMINISTRATION, INTRANASAL; ANIMALS; ATROPHY; BRAIN; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; ISCHEMIC PRECONDITIONING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; MOTOR ACTIVITY; NERVOUS SYSTEM DISEASES; NEUROGENESIS; NEUROPEPTIDES; PSYCHOMOTOR PERFORMANCE; RECOVERY OF FUNCTION; STROKE; TIME FACTORS;

EID: 84956956932     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2015.03.011     Document Type: Article

References (60)

1. Andres, R.H., et al. Cell replacement therapy for intracerebral hemorrhage. Neurosurg. Focus., 24(3–4), 2008, E16.
2. Ara, J., De Montpellier, S., Hypoxic-preconditioning enhances the regenerative capacity of neural stem/progenitors in subventricular zone of newborn piglet brain. Stem Cell Res. 11:2 (2013), 669–686.
3. Banerjee, S., et al. The potential benefit of stem cell therapy after stroke: an update. Vasc. Health Risk Manag. 8 (2012), 569–580.
4. Beray-Berthat, V., et al. Long-term histological and behavioural characterisation of a collagenase-induced model of intracerebral haemorrhage in rats. J. Neurosci. Methods 191:2 (2010), 180–190.
5. Bliss, T., et al. Cell transplantation therapy for stroke. Stroke 38:2 Suppl. (2007), 817–826.
6. Chapman, C.D., et al. Intranasal treatment of central nervous system dysfunction in humans. Pharm. Res. 30:10 (2013), 2475–2484.
7. Chen, S.J., et al. Brain-derived neurotrophic factor-transfected and nontransfected 3T3 fibroblasts enhance migratory neuroblasts and functional restoration in mice with intracerebral hemorrhage. J. Neuropathol. Exp. Neurol. 71:12 (2012), 1123–1136.
8. Danielyan, L., et al. Intranasal delivery of cells to the brain. Eur. J. Cell Biol. 88:6 (2009), 315–324.
9. Das, R., et al. The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Eng. Part B Rev. 16:2 (2010), 159–168.
10. Donega, V., et al. Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS One, 8(1), 2013, e51253.
11. Fagan, S.C., et al. Recommendations for preclinical research in hemorrhagic transformation. Transl. Stroke Res. 4:3 (2013), 322–327.
12. Fischer, U.M., et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 18:5 (2009), 683–692.
13. Francis, K.R., Wei, L., Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning. Cell Death Dis., 1, 2010, e22.
14. Hu, X., et al. Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation. Am. J. Physiol. Cell Physiol. 301:2 (2011), C362–C372.
15. Ishizaka, S., et al. Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke 44:3 (2013), 720–726.
16. Jiang, Y., et al. Intranasal delivery of stem cells to the brain. Expert Opin. Drug Deliv. 8:5 (2011), 623–632.
17. Jin, K., et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc. Natl. Acad. Sci. U. S. A. 98:8 (2001), 4710–4715.
18. Kan, E.M., Ling, E.A., Lu, J., Stem cell therapy for spinal cord injury. Curr. Med. Chem. 17:36 (2010), 4492–4510.
19. Kang, S., Kim, S.M., Sung, J.H., Cellular and molecular stimulation of adipose-derived stem cells under hypoxia. Cell Biol. Int. 38:5 (2014), 553–562.
20. Keep, R.F., Hua, Y., Xi, G., Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 11:8 (2012), 720–731.
21. Kircher, M.F., Gambhir, S.S., Grimm, J., Noninvasive cell-tracking methods. Nat. Rev. Clin. Oncol. 8:11 (2011), 677–688.
22. Kleinig, T.J., Vink, R., Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options. Curr. Opin. Neurol. 22:3 (2009), 294–301.
23. Krafft, P.R., et al. Modeling intracerebral hemorrhage in mice: injection of autologous blood or bacterial collagenase. J. Vis. Exp., 67, 2012, e4289.
24. Lee, H.J., et al. Human neural stem cells overexpressing glial cell line-derived neurotrophic factor in experimental cerebral hemorrhage. Gene Ther. 16:9 (2009), 1066–1076.
25. Lei, C., et al. Effects of high-mobility group box1 on cerebral angiogenesis and neurogenesis after intracerebral hemorrhage. Neuroscience 229 (2013), 12–19.
26. Li, F., et al. Therapeutic time window and effect of intracarotid neural stem cells transplantation for intracerebral hemorrhage. Neuroreport 18:10 (2007), 1019–1023.
27. Li, W.L., et al. Enhanced neurogenesis and cell migration following focal ischemia and peripheral stimulation in mice. Dev. Neurobiol. 68:13 (2008), 1474–1486.
28. Liang, H., et al. Transplantation of bone marrow stromal cells enhances nerve regeneration of the corticospinal tract and improves recovery of neurological functions in a collagenase-induced rat model of intracerebral hemorrhage. Mol. Cells 36:1 (2013), 17–24.
29. Liu, L., et al. Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF. Cell Biol. Int. 37:6 (2013), 551–560.
30. Liu, X., et al. Cell based therapies for ischemic stroke: from basic science to bedside. Prog. Neurobiol. 115 (2014), 92–115.
31. Lochhead, J.J., Thorne, R.G., Intranasal delivery of biologics to the central nervous system. Adv. Drug Deliv. Rev. 64:7 (2012), 614–628.
32. Mahmood, A., et al. Treatment of traumatic brain injury with a combination therapy of marrow stromal cells and atorvastatin in rats. Neurosurgery 60:3 (2007), 546–553 (discussion 553–554).
33. Masuda, T., et al. Increase in neurogenesis and neuroblast migration after a small intracerebral hemorrhage in rats. Neurosci. Lett. 425:2 (2007), 114–119.
34. Miao, Z., et al. Hypothermia induced by adenosine 5'-monophosphate attenuates early stage injury in an acute gouty arthritis rat model. Rheumatol. Int. 33:8 (2013), 2085–2092.
35. Mohan, S., et al. Putative role of prostaglandin receptor in intracerebral hemorrhage. Front. Neurol., 3, 2012, 145.
36. Onteniente, B., The multiple aspects of stroke and stem cell therapy. Curr. Mol. Med. 13:5 (2013), 821–831.
37. Osanai, T., et al. Noninvasive transplantation of bone marrow stromal cells for ischemic stroke: preliminary study with a thermoreversible gelation polymer hydrogel. Neurosurgery 66:6 (2010), 1140–1147 (discussion 1147).
38. Otero, L., et al. Intralesional administration of allogeneic bone marrow stromal cells reduces functional deficits after intracerebral hemorrhage. Histol. Histopathol. 25:4 (2010), 453–461.
39. Otero, L., et al. Late transplantation of allogeneic bone marrow stromal cells improves neurologic deficits subsequent to intracerebral hemorrhage. Cytotherapy 13:5 (2011), 562–571.
40. Otero, L., et al. Allogeneic bone marrow stromal cell transplantation after cerebral hemorrhage achieves cell transdifferentiation and modulates endogenous neurogenesis. Cytotherapy 14:1 (2012), 34–44.
41. Poon, M.T., Fonville, A.F., Al-Shahi Salman, R., Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 85:6 (2013), 660–667.
42. Qin, J., et al. Functional recovery after transplantation of induced pluripotent stem cells in a rat hemorrhagic stroke model. Neurosci. Lett. 554 (2013), 70–75.
43. Ruan, L., et al. Neurogenesis in neurological and psychiatric diseases and brain injury: from bench to bedside. Prog. Neurobiol. 115 (2013), 116–137.
44. Seyfried, D.M., et al. Localization of bone marrow stromal cells to the injury site after intracerebral hemorrhage in rats. J. Neurosurg. 112:2 (2010), 329–335.
45. Song, M., et al. Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice. Cell Transplant. 22:11 (2013), 2001–2015.
46. Stahel, P.F., et al. Experimental closed head injury: analysis of neurological outcome, blood–brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J. Cereb. Blood Flow Metab. 20:2 (2000), 369–380.
47. Sun, Y., et al. Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in mice. J. Neurotrauma 28:12 (2011), 2513–2521.
48. Theus, M.H., et al. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp. Neurol. 210:2 (2008), 656–670.
49. Vaquero, J., et al. Cell therapy with bone marrow stromal cells after intracerebral hemorrhage: impact of platelet-rich plasma scaffolds. Cytotherapy 15:1 (2013), 33–43.
50. Wang, L., et al. Therapeutic applications of bone marrow-derived stem cells in ischemic stroke. Neurol. Res. 35:5 (2013), 470–478.
51. Wei, L., et al. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol. Dis. 46:3 (2012), 635–645.
52. Wei, N., et al. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell Transplant. 22:6 (2013), 977–991.
53. Wei, S., et al. Acute and delayed protective effects of pharmacologically induced hypothermia in an intracerebral hemorrhage stroke model of mice. Neuroscience 252 (2013), 489–500.
54. Wei, Z.Z., et al. Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats. Cell Transplant., 2015 [Epub ahead of print].
55. Wu, S., et al. Intranasal delivery of neural stem cells: a CNS-specific, non-invasive cell-based therapy for experimental autoimmune encephalomyelitis. J. Clin. Cell Immunol., 4(3), 2013.
56. Xiong, X.Y., et al. Iron and intracerebral hemorrhage: from mechanism to translation. Transl. Stroke Res. 5:4 (2013), 429–441.
57. Xue, M., Del Bigio, M.R., Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci. Lett. 283:3 (2000), 230–232.
58. Yang, C., et al. Neuroprotective effects of bone marrow stem cells overexpressing glial cell line-derived neurotrophic factor on rats with intracerebral hemorrhage and neurons exposed to hypoxia/reoxygenation. Neurosurgery 68:3 (2011), 691–704.
59. Yang, K.L., et al. Human adipose-derived stem cells for the treatment of intracerebral hemorrhage in rats via femoral intravenous injection. Cell. Mol. Biol. Lett. 17:3 (2012), 376–392.
60. Yu, S.P., Wei, Z., Wei, L., Preconditioning strategy in stem cell transplantation therapy. Transl. Stroke Res. 4:1 (2013), 76–88.